Get started
Novartis AGNovartis AGNovartis AG

Novartis AG

No trades
OverviewFinancialsNewsDocumentsCommunityTechnicalsForecastsSeasonalsBondsETFs
Full chart
Full chart

Key facts today


Novartis (NOVN) warned H1 2026 headwinds from generic competition to Entresto, Tasigna and Promacta; full-year 2026 guides low single-digit sales growth (cc) and slight core op profit decline.
Analyze the impactAnalyze the impact

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪207.57 B‬ CHF
Dividend yield (indicated)
3.25%
Price to earnings Ratio (TTM)
19.50
Basic EPS (TTM)
6.00 CHF
Net income (FY)
‪11.61 B‬ CHF
Revenue (FY)
‪45.29 B‬ CHF
Shares float
‪1.62 B‬
Beta (1Y)
0.05

Employees


Employees (FY)
‪75.27 K‬
Change (1Y)
−616 −0.81%
Revenue / Employee (1Y)
‪601.70 K‬ CHF
Net income / Employee (1Y)
‪154.30 K‬ CHF

About Novartis AG


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Vasant Narasimhan
Website
novartis.com
Headquarters
Basel
Founded
1996
IPO date
May 7, 2001
Identifiers
2
ISIN CH0012005267
CFI code
ESVTFR
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Check out other big names from the same industry as NOVN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


5.644% YTM
Maturity date Mar 18, 2056
Coupon 5.70% (Fixed)
5.565% YTM
Maturity date Sep 18, 2054
Coupon 4.70% (Fixed)
5.564% YTM
Maturity date Nov 5, 2055
Coupon 5.30% (Fixed)
5.541% YTM
Maturity date Aug 14, 2050
Coupon 2.75% (Fixed)
5.536% YTM
Maturity date Mar 18, 2046
Coupon 5.60% (Fixed)
5.477% YTM
Maturity date Nov 5, 2045
Coupon 5.20% (Fixed)
5.477% YTM
Maturity date May 6, 2044
Coupon 4.40% (Fixed)
5.460% YTM
Maturity date Nov 20, 2045
Coupon 4.00% (Fixed)
5.361% YTM
Maturity date Sep 21, 2042
Coupon 3.70% (Fixed)
4.929% YTM
Maturity date Mar 18, 2036
Coupon 4.90% (Fixed)
4.828% YTM
Maturity date Nov 5, 2035
Coupon 4.60% (Fixed)

See all NOVN bonds 

ETFs holding the stock


VXUS
Vanguard Total International Stock ETF
Weight 0.72%
Market value ‪4.31 B‬
VEA
Vanguard FTSE Developed Markets ETF
Weight 1.00%
Market value ‪2.85 B‬
IEFA
iShares Core MSCI EAFE ETF
Weight 1.10%
Market value ‪1.96 B‬
CHDVD
iShares Swiss Dividend ETF (CH)
Weight 13.78%
Market value ‪1.26 B‬
EFA
iShares MSCI EAFE ETF
Weight 1.29%
Market value ‪962.81 M‬
CHSPI
iShares Core SPI(R) ETF (CH)
Weight 12.86%
Market value ‪881.47 M‬
SMICHA
UBS ETF (CH) - SMI ETF -CHF dis-
Weight 17.35%
Market value ‪796.35 M‬
SMIA
UBS ETF (CH) - SMI ETF Units -CHF acc-
Weight 17.35%
Market value ‪796.35 M‬
VGK
Vanguard FTSEEuropean ETF
Weight 1.98%
Market value ‪731.40 M‬
VEU
Vanguard FTSE All World Ex US ETF
Weight 0.79%
Market value ‪678.09 M‬
SCHF
Schwab International Equity ETF
Weight 1.01%
Market value ‪626.17 M‬

Explore more ETFs 

Frequently asked questions


The current price of NOVN is 114.08 CHF — it has decreased by −2.22% in the past 24 hours. Watch Novartis AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange Novartis AG stocks are traded under the ticker NOVN.
NOVN stock has fallen by −2.94% compared to the previous week, the month change is a −3.84% fall, over the last year Novartis AG has showed a 23.58% increase.
We've gathered analysts' opinions on Novartis AG future price: according to them, NOVN price has a max estimate of 141.27 CHF and a min estimate of 91.38 CHF. Watch NOVN chart and read a more detailed Novartis AG stock forecast: see what analysts think of Novartis AG and suggest that you do with its stocks.
NOVN reached its all-time high on Feb 27, 2026 with the price of 131.00 CHF, and its all-time low was 34.40 CHF and was reached on Aug 11, 2011. View more price dynamics on NOVN chart.
See other stocks reaching their highest and lowest prices.
NOVN stock is 1.08% volatile and has beta coefficient of 0.05. Track Novartis AG stock price on the chart and check out the list of the most volatile stocks — is Novartis AG there?
Today Novartis AG has the market capitalization of ‪208.13 B‬, it has decreased by −1.57% over the last week.
Yes, you can track Novartis AG financials in yearly and quarterly reports right on TradingView.
Novartis AG is going to release the next earnings report on Apr 28, 2026. Keep track of upcoming events with our Earnings Calendar.
NOVN earnings for the last quarter are 1.61 CHF per share, whereas the estimation was 1.58 CHF resulting in a 2.09% surprise. The estimated earnings for the next quarter are 1.68 CHF per share. See more details about Novartis AG earnings.
Novartis AG revenue for the last quarter amounts to ‪10.57 B‬ CHF, despite the estimated figure of ‪10.88 B‬ CHF. In the next quarter, revenue is expected to reach ‪10.76 B‬ CHF.
NOVN net income for the last quarter is ‪1.93 B‬ CHF, while the quarter before that showed ‪3.14 B‬ CHF of net income which accounts for 0.00% change. Track more Novartis AG financial stats to get the full picture.
Yes, NOVN dividends are paid annually. The last dividend per share was 3.70 CHF. As of today, Dividend Yield (TTM)% is 3.25%. Tracking Novartis AG dividends might help you take more informed decisions.
Novartis AG dividend yield was 3.38% in 2025, and payout ratio reached 61.77%. The year before the numbers were 3.95% and 67.17% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 28, 2026, the company has ‪75.27 K‬ employees. See our rating of the largest employees — is Novartis AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Novartis AG EBITDA is ‪18.41 B‬ CHF, and current EBITDA margin is 40.92%. See more stats in Novartis AG financial statements.
Like other stocks, NOVN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Novartis AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Novartis AG technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Novartis AG stock shows the buy signal. See more of Novartis AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.